Adjunctive Effects of A Piscean Collagen-Based Controlled-Release Chlorhexidine Chip in the Treatment of Chronic Periodontitis: A Clinical and Microbiological Study
- PMID: 26155567
- PMCID: PMC4484159
- DOI: 10.7860/JCDR/2015/11534.5965
Adjunctive Effects of A Piscean Collagen-Based Controlled-Release Chlorhexidine Chip in the Treatment of Chronic Periodontitis: A Clinical and Microbiological Study
Abstract
Introduction: PerioChip a bovine origin gelatine based CHX chip has shown beneficial effects in the management of Chronic Periodontitis. A new fish collagen based CHX chip similar to PerioChip is currently available; however this product has not been thoroughly researched.
Aim: The aim of the present study was to evaluate the effectiveness of a new Piscean collagen-based controlled-release chlorhexidine chip (CHX chip) as an adjunctive therapy to scaling and root planing (SRP).
Settings and design: The study was conducted as a randomised, split-mouth, controlled clinical trial at Krishnadevaraya College of Dental Sciences, Bangalore, India.
Materials and methods: In a split-mouth study involving 20 sites in 10 patients with chronic periodontitis, control sites received scaling and root planing and test sites received scaling and root planing (SRP) and the intrapocket CHX chip placement as an adjunct. Subgingival plaque samples were collected from both control and test sites at baseline, 11 days and 11 weeks and the anaerobic colony count were assessed. Clinical parameters that were recorded at baseline and 11 weeks were gingival index, Plaque index, Probing pocket depth (PPD), and Clinical attachment level (CAL). Plaque index was recorded additionally at 11 days.
Results: In the test group there was a statistically significant reduction in the total anaerobic colony count, gingival index and plaque scores from baseline as compared to control sites at all time intervals. An additional 0.8mm reduction in mean probing pocket depth was noted in the test group. Gain in Clinical attachment level was comparable in both groups.
Conclusion: The adjunctive use of the new collagen-based CHX chip yielded significant antimicrobial benefit accompanied by a reduction in probing depth and a clinical attachment level gain as compared to SRP alone. This suggests that it may be a useful treatment option of nonsurgical periodontal treatment of chronic periodontitis.
Keywords: Chlorhexidine; Chronic periodontitis; Dental plaque; Drug delivery systems; Microbiological analysis.
Figures
References
-
- Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol. 1990;17:479–95. - PubMed
-
- Rams T, Slots J. Local delivery of antimicrobial agents in the periodontal pocket. Periodontol 2000. 1996;10:139–59. - PubMed
-
- Quirynen M, Teughels W, van Steenberghe D. Microbial shifts after subgingival debridement and formation of bacterial resistance when combined with local or systemic antimicrobials. Oral Dis. 2003;9(Suppl 1):30–37. - PubMed
-
- Addy M, Martin MV. Systemic antimicrobials in the treatment of chronic periodontal diseases: a dilemma. Oral Dis. 2003;9(Suppl 1):38–44. - PubMed
-
- Salvi GE, Mombelli A, Mayfield L, Rutar A, Suvan J, Garrett S, et al. Local antimicrobial therapy after initial periodontal treatment. A randomized clinical trial comparing three biodegradable sustained release polymers. J Clin Periodontol. 2002;29:540–50. - PubMed
LinkOut - more resources
Full Text Sources